Kidney-Metabolic Factors Associated with Cognitive Impairment in Chronic Kidney Disease: A Pilot Study

Abstract

<b><i>Introduction:</i></b> The associations of kidney-metabolic biomarkers with cognitive impairment (CI) beyond the estimated glomerular filtration rate (eGFR, in mL/min/1.73 m<sup>2</sup>) and albuminuria levels are not well understood. In exploratory analysis, our objective was to determine the extent that three kidney-metabolic factors, previously proposed as mechanisms of CI and commonly abnormal in chronic kidney disease (CKD), were associated with prevalent CI in CKD participants, adjusted for kidney function measures. <b><i>Methods:</i></b> The study cohort included community-dwelling individuals aged ≥45 years with CKD (eGFR <60), not requiring dialysis, recruited from four health systems. We examined the serum biomarkers bicarbonate (CO<sub>2</sub>), TNFαR1, and cholesterol as primary exposures. A structured neuropsychological battery conducted by trained staff measured global and domain-specific cognitive performance. Logistic regression analyses estimated the cross-sectional associations between kidney-metabolic measures and global and cognitive domain-specific moderate/severe (Mod/Sev) CI, adjusted for the eGFR, urinary albumin-creatinine ratio (UACR, mg/g), demographics, comorbid conditions, and other kidney-metabolic biomarkers commonly abnormal in CKD. <b><i>Results:</i></b> Among 436 CKD participants with mean age 70 years, 16% were Black, the mean eGFR was 34, and the median [IQR] UACR was 49 [0.0, 378] mg/g. In adjusted models, increased TNFαR1 was associated with global Mod/Sev CI (odds ratio [95% confidence interval] = 1.40 [1.02, 1.93]; <i>p</i> = 0.04); low bicarbonate (CO<sub>2</sub> <20 mEq/L) with Mod/Sev memory impairment (3.04 [1.09, 8.47]; <i>p</i> = 0.03), and each 10-mg/dL lower cholesterol was associated with Mod/Sev executive function/processing speed impairment (1.12 [1.02, 1.23]; <i>p</i> = 0.02). However, after adjustment for multiple comparisons, these associations were no longer significant nor were any other kidney-metabolic factors significant for any CI classification. <b><i>Conclusion:</i></b> In exploratory analyses in a CKD population, three kidney-metabolic factors were associated with CI, but after adjustment for multiple comparisons, were no longer significant. Future studies in larger CKD populations are needed to assess these potential risk factors for CI.

Association of cognitive impairment with the interaction between chronic kidney disease and depression: findings from NHANES 2011–2014

“…The study sample found a significant positive correlation between CKD and CoI. This finding is consistent with a previously reported prospective study that observed a correlation between declining kidney function and CoI, even in patients with mild CKD [ 36 ]. Another large-scale national study in the United States revealed that CKD is associated with an increased prevalence of CoI, which rises by 11% for every 10 mL/min/1.73 m 2 (< 60 mL/min/1.73 m 2 ) decrease in eGFR [ 37 ].…”